X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1272) 1272
Book Review (164) 164
Publication (64) 64
Magazine Article (8) 8
Book / eBook (7) 7
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1183) 1183
female (1181) 1181
humans (1177) 1177
middle aged (772) 772
estrogens, conjugated - adverse effects (627) 627
estrogens, conjugated - administration & dosage (478) 478
estrogens, conjugated - therapeutic use (469) 469
aged (416) 416
menopause (379) 379
abridged index medicus (372) 372
estrogen replacement therapy - adverse effects (366) 366
postmenopausal women (347) 347
estrogen (337) 337
adult (328) 328
hormone replacement therapy (326) 326
obstetrics & gynecology (289) 289
postmenopause (284) 284
estrogen replacement therapy (253) 253
risk (235) 235
risk factors (217) 217
double-blind method (206) 206
women (200) 200
estrogens, conjugated - pharmacology (196) 196
hormone therapy (191) 191
medroxyprogesterone acetate - adverse effects (191) 191
medicine, general & internal (171) 171
medroxyprogesterone acetate - administration & dosage (170) 170
time factors (144) 144
drug therapy, combination (142) 142
estrogens - adverse effects (136) 136
animals (127) 127
treatment outcome (123) 123
health aspects (121) 121
estradiol - administration & dosage (120) 120
medroxyprogesterone acetate - therapeutic use (119) 119
replacement therapy (110) 110
medroxyprogesterone acetate (109) 109
dose-response relationship, drug (107) 107
drug combinations (99) 99
estrogen replacement therapy - methods (99) 99
prospective studies (99) 99
randomized controlled trials as topic (98) 98
follow-up studies (97) 97
estradiol (96) 96
conjugated equine estrogens (93) 93
estradiol - adverse effects (92) 92
randomized controlled-trial (92) 92
endocrinology & metabolism (91) 91
breast neoplasms - chemically induced (90) 90
women's health (89) 89
estrogens - administration & dosage (88) 88
geriatrics & gerontology (88) 88
estrogens - therapeutic use (87) 87
menopause - drug effects (86) 86
administration, oral (85) 85
plus progestin (83) 83
estrogens (82) 82
lipids - blood (82) 82
cardiovascular-disease (81) 81
male (81) 81
drug administration schedule (80) 80
osteoporosis (75) 75
estrogen plus progestin (73) 73
prevention (73) 73
conjugated estrogens (72) 72
administration, cutaneous (70) 70
estradiol - therapeutic use (70) 70
womens health (70) 70
postmenopause - drug effects (69) 69
clinical trials (67) 67
breast-cancer (66) 66
hormones (66) 66
hysterectomy (65) 65
disease (64) 64
breast cancer (62) 62
estradiol - analogs & derivatives (62) 62
osteoporosis, postmenopausal - prevention & control (62) 62
bone density - drug effects (61) 61
breast neoplasms - epidemiology (61) 61
coronary disease - prevention & control (61) 61
hormone replacement therapy - adverse effects (61) 61
research (58) 58
triglycerides - blood (58) 58
endometrium - drug effects (57) 57
ovariectomy (57) 57
age factors (56) 56
hot flashes - drug therapy (56) 56
cardiovascular diseases - prevention & control (55) 55
coronary-heart-disease (55) 55
placebos (55) 55
risk assessment (55) 55
clinical trials as topic (54) 54
progesterone congeners - adverse effects (53) 53
therapy (53) 53
cholesterol - blood (52) 52
cardiovascular disease (51) 51
climacteric - drug effects (50) 50
cholesterol, hdl - blood (49) 49
incidence (49) 49
pharmacology & pharmacy (49) 49
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1213) 1213
German (37) 37
French (10) 10
Swedish (6) 6
Japanese (5) 5
Spanish (5) 5
Italian (4) 4
Chinese (3) 3
Dutch (2) 2
Russian (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 2013, Volume 310, Issue 13, pp. 1353 - 1368
IMPORTANCE Menopausal hormone therapy continues in clinical use but questions remain regarding its risks and benefits for chronic disease prevention. OBJECTIVE... 
BREAST-CANCER | INSOMNIA RATING-SCALE | MEDICINE, GENERAL & INTERNAL | REPLACEMENT THERAPY | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | ESTROGEN PLUS PROGESTIN | CORONARY-HEART-DISEASE | MILD COGNITIVE IMPAIRMENT | POSTMENOPAUSAL WOMEN | CONJUGATED EQUINE ESTROGEN | United States - epidemiology | Follow-Up Studies | Humans | Middle Aged | Coronary Disease - epidemiology | Risk | Hormone Replacement Therapy - adverse effects | Pulmonary Embolism - epidemiology | Estrogens - adverse effects | Medroxyprogesterone Acetate - adverse effects | Postmenopause | Female | Stroke - epidemiology | Drug Therapy, Combination | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Estrogens, Conjugated (USP) - administration & dosage | Treatment Outcome | Endometrial Neoplasms - epidemiology | Hip Fractures - epidemiology | Breast Neoplasms - prevention & control | Coronary Disease - prevention & control | Quality of Life | Aged | Medroxyprogesterone Acetate - administration & dosage | Estrogens, Conjugated (USP) - adverse effects | Estrogens - administration & dosage | Women | Care and treatment | Research | Hormone therapy | Health aspects | Menopause | Womens health | Estrogen | Endocrine therapy | Clinical trials | Cardiovascular disease | Breast cancer | Progesterone | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 02/2014, Volume 99, Issue 2, pp. E189 - E198
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2017, Volume 318, Issue 10, pp. 927 - 938
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2009, Volume 92, Issue 3, pp. 1025 - 1038
Objective To evaluate the effects of a tissue-selective estrogen complex (TSEC) composed of bazedoxifene/conjugated estrogens (BZA/CE) on menopausal symptoms,... 
Internal Medicine | Obstetrics and Gynecology | breast pain | Bazedoxifene | hot flushes | metabolism | vaginal atrophy | conjugated estrogens | coagulation | PLACEBO | RISK-FACTORS | MEDROXYPROGESTERONE ACETATE | OSTEOPOROSIS | OBSTETRICS & GYNECOLOGY | TRIAL | REPRODUCTIVE BIOLOGY | DISEASE | POSTMENOPAUSAL WOMEN | RECEPTOR MODULATOR | LIPIDS | Carbohydrate Metabolism - drug effects | Estrogens, Conjugated (USP) - pharmacology | Estrogens - pharmacology | Vagina - drug effects | Humans | Middle Aged | Atrophy - pathology | Selective Estrogen Receptor Modulators - adverse effects | Homocysteine - metabolism | Estrogens - adverse effects | Estrogens - therapeutic use | Dose-Response Relationship, Drug | Menopause - drug effects | Selective Estrogen Receptor Modulators - therapeutic use | Adult | Female | Indoles - pharmacology | Atrophy - drug therapy | Drug Therapy, Combination | Vagina - pathology | Hot Flashes - drug therapy | Double-Blind Method | Treatment Outcome | Estrogens, Conjugated (USP) - therapeutic use | Indoles - adverse effects | Menopause - metabolism | Outpatients | Lipid Metabolism - drug effects | Indoles - therapeutic use | Aged | Estrogens, Conjugated (USP) - adverse effects | Selective Estrogen Receptor Modulators - pharmacology | Benzoic acid | Women | Medical colleges | Care and treatment | Safety and security measures | Analysis | Menopause | Estrogen | Health aspects | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2009, Volume 92, Issue 3, pp. 1018 - 1024
Journal Article
JAMA, ISSN 0098-7484, 10/2010, Volume 304, Issue 15, pp. 1684 - 1692
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 08/2014, Volume 161, Issue 4, pp. 249 - 260
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 7/2009, Volume 170, Issue 1, pp. 12 - 23
The authors further analyzed results from the Women's Health Initiative randomized trials (1993-2004) of conjugated equine estrogens, with or without... 
Estrogen replacement therapy | Estrogens | Cohort studies | Progestins | Postmenopause | Clinical trial | Hormone replacement therapy | Medroxyprogesterone 17-acetate | clinical trial | progestins | CONJUGATED EQUINE ESTROGENS | CLINICAL-TRIAL | estrogens | VENOUS THROMBOSIS | RANDOMIZED CONTROLLED-TRIAL | BREAST-CANCER | WOMEN | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | estrogen replacement therapy | COLORECTAL-CANCER | cohort studies | hormone replacement therapy | CARDIOVASCULAR-DISEASE | postmenopause | ESTROGEN PLUS PROGESTIN | CORONARY-HEART-DISEASE | medroxyprogesterone 17-acetate | Contraceptive Agents, Female - adverse effects | Postmenopause - drug effects | Follow-Up Studies | Contraceptive Agents, Female - therapeutic use | Progestins - therapeutic use | Humans | Menopause | Middle Aged | Progestins - adverse effects | Fractures, Bone - epidemiology | Coronary Disease - epidemiology | Pulmonary Embolism - epidemiology | Estrogens - adverse effects | Estrogens - therapeutic use | Incidence | Washington - epidemiology | Time Factors | Medroxyprogesterone Acetate - adverse effects | Female | Stroke - epidemiology | Retrospective Studies | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Survival Rate - trends | Estrogens, Conjugated (USP) - administration & dosage | Risk Factors | Medroxyprogesterone Acetate - therapeutic use | Thrombosis - epidemiology | Endometrial Neoplasms - epidemiology | Estrogen Replacement Therapy - adverse effects | Breast Neoplasms - prevention & control | Estrogens, Conjugated (USP) - therapeutic use | Coronary Disease - prevention & control | Aged | Estrogens, Conjugated (USP) - adverse effects | Fractures, Bone - prevention & control | Hormone therapy | Conjugated estrogens | Causes of | Postmenopausal women | Breast cancer | Drug therapy | Thromboembolism | Health aspects | Risk factors | Clinical trials | Womens health | Epidemiology | Clinical outcomes | Index Medicus | Original Contributions
Journal Article